IPEC Europe is the association that brings together producers, distributors and users of pharmaceuticals excipients. IPEC Europe counts 71 full members, 4 associate members and 5 co-opted members.

Board

Frithjof Holtz

IPEC Europe Chair

Mr. Frithjof Holtz is a biologist and has been working for almost 30 years with Merck KGaA, Darmstadt, Germany, having a long year experience in quality assurance and regulatory affairs. Besides experience in chemical manufacturing (excipients/APIs) he has also working experience in quality assurance for drug products (sterile/non-sterile).

Furthermore, he is now working for almost 15 years in Regulatory Affairs (CMC) for pharmaceutical starting materials. Currently he is responsible for the coordination of the advocacy & surveillance activities of Merck Life Science.

Frank Milek

IPEC Europe Vice-Chair

Dr. Frank Milek is an industrial pharmacist and has been working in pharmaceutical excipients industry for more than 15 years, specialised in the field of supply chain and distribution. He is registered QP according to EU regulation and responsible at Aug. Hedinger GmbH & Co. KG for Quality, Regulatory Affairs and GMP.

Frank is the President of the IPEC Federation and an active member of the EXCiPACT project.

Karine Roth

IPEC Europe Secretary

Karine Roth is a Pharmacist and has more than 20 years of experience within Pharmaceutical Industry.

She is currently working with Novartis as Global Head Quality Cell & Gene Therapy (C>) Network; her role includes Quality oversight for development, commercialization and manufacturing of C> therapies for all Novartis assets. Previously she used to lead different quality organization looking at Technical development of Biologics, QA Oversight of suppliers and parenteral contract manufacturers.

Prior Novartis, she has worked for Eli Lilly in several management position in Regulatory, Quality Assurance and Operational Excellence.

Amina Faham

IPEC Europe Board Member

Amina is a highly effective senior leader with several years of experience in leadership, generating business growth thru technology expertise and creating value for customers utilizing business acumen. 

Amina earned a Ph.D. degree in Pharmaceutical Sciences from school of Pharmacy, University de la Mediterranean France. She has over 15 years of Healthcare industry experience and have worked for several pharmaceutical and chemical companies. Amina offers an array of skills in customer-centric cultures, logical problem solving, and cross-functional collaboration, team leadership, strengthening competitive position, business development and talent acquisition.

She joined The Dow Chemical Company in Switzerland in 2011 as a Pharma application specialist to support the business growth in EMEA, and then she moved into leadership role within R&D organization. Since April 2018, Amina is leading the DuPont Pharma Solutions application development & innovation team, and one of her main responsibilities is to build, develop and lead high performing global team for high impact on business growth and value creation in the market, and to use her external network and strategic thinking to closely connect to the innovation needs of the healthcare industry.

For several years, Amina has been an engaged thought leader and business advocate. She is an executive board member of the International Pharmaceutical Excipients Council in Europe, a lecturer at Zurich Federal Institute of Technology (ETH), Chairs the DuPont N&B global Diversity Equity & Inclusion steering committee, and co-chairs the Global DuPont Women Network.

She also engages in the community high schoolers on Diversity & Inclusion that is a key asset for a business growth. Amina and her family have lived in multiple countries, experienced different cultures, languages, foods and has made priceless discoveries and memories.

Liz Meehan

IPEC Europe Board Member

Liz Meehan is a material scientist with a PhD from City University, London and more than 30 years experience in material characterisation.

She has worked in the pharmaceutical industry for 10 years, in the Pharmaceutical Development department of AstraZeneca, specialising in the field of excipient characterisation, relating excipient properties to functionality in dosage form design. More generally her activities include excipient risk assessment/mitigation for the development of robust pharmaceutical formulations.

Mahmud Yunis

IPEC Europe Board Member

Dr. Mahmud Yunis has been working for 13 years at BIOGRUND in several positions.

In his current function as Technical Director, he is responsible for preparing and implementing global strategic regulatory plan for BIOGRUND products and the strategic development of the Quality, Production and R&D department. He has a PhD degree in Analytical Chemistry from University of Muenster, Germany.  Before joining BIOGRUND he worked for a consulting company on the area of GxP procedures and processes for five years.

Karsten Diehl

IPEC Europe Treasurer

Karsten Diehl is a biotechnologist and has been working for more than 20 years in the regulated pharmaceutical and health care environmental.

He joined BASF SE Ludwigshafen, Germany in 2011 and is part of the BASF Pharma Solutions global quality department. Karsten has experience in manufacturing pharmaceutical ingredients, contract manufacture handling, supply chain and distribution as well as general Quality- and GMP-Compliance topics.

Prior BASF SE, he has worked for Procter & Gamble within several quality position in Quality Assurance and Operational Excellence.

Kevin Hughes

IPEC Europe Board Member

Kevin has been with Colorcon for over 15 years where he has been the Technical Expert in film coating, immediate release excipients and extended release excipients.
Kevin is now Regulatory Affairs and Quality Assurance Manager for Colorcon and is responsible for the EMEA region, providing regulatory support to customers in both the pharmaceutical and food industries, monitoring any regulatory changes, industry initiatives and is closely involved with the IPEC Quality and Regulatory Affairs Committee. Kevin is also responsible for Quality at the Dartford site, and hosting of all customer and certification audits as well as conducting supplier audits as an IRCA qualified Lead Auditor.
Prior to Colorcon, Kevin spent 5 years at Boots Healthcare Development, where he was Team Leader developing solid oral dosage forms for Boots Pharmacies. Kevin graduated with from Nottingham University in 1994. He has been involved in the pharmaceutical industry for 20 years.